Kyrgyzstan vs Portugal: Mental health and substance use disorders deaths
Kyrgyzstan
258.99 deaths
in 2021
Portugal
288.01 deaths
in 2021
Kyrgyzstan rank
88th
Portugal rank
86th
Mental health and substance use disorders deaths over time
- Kyrgyzstan
- Portugal
How they compare
Portugal currently reports 288.01 deaths against 258.99 deaths in Kyrgyzstan, a difference of 29.02 deaths.
That makes Portugal's figure about 1.1 times Kyrgyzstan's.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 88th and Portugal ranks 86th of 194 countries.
Across the 3 decades both report, Kyrgyzstan averaged higher in 2 and Portugal in 1.
Head to head by decade
| Decade | Kyrgyzstan | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 553.83 deaths | 212.74 deaths | 341.09 deaths | Kyrgyzstan |
| 2010s | 390.58 deaths | 235.61 deaths | 154.97 deaths | Kyrgyzstan |
| 2020s | 268.28 deaths | 291.9 deaths | 23.62 deaths | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mental health and substance use disorders deaths, Kyrgyzstan or Portugal?
- Portugal, at 288.01 deaths against 258.99 deaths in Kyrgyzstan as of 2021.
- What is the difference in mental health and substance use disorders deaths between Kyrgyzstan and Portugal?
- 29.02 deaths, with Portugal ahead.
- How many years of comparable data are there for Kyrgyzstan and Portugal?
- 22 years are reported by both, from 2000 to 2021.
- How do Kyrgyzstan and Portugal rank globally for mental health and substance use disorders deaths?
- Kyrgyzstan ranks 88th and Portugal ranks 86th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Mental health and substance use disorders deaths. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from mental and substance use disorders in both sexes.